Central Nervous System (CNS), Real World Evidence
In the following article by the Journal for Clinical Studies, Henry J. Riordan, Michael Murphy, Eric D Perakslis, and Sam Roosz discuss how to use large data sets and extended trial observations to close the Alzheimer’s real-world evidence gap.
Real World Evidence
Ready to chat about your real-world evidence program? Dr. Michael Murphy discusses real-world evidence and what happens after a clinical trial.
Early Phase, Lab Services
In this video, 3 experts share what makes the Worldwide Clinical Trials Early Phase Program, including the Bioanalytical Lab and Clinical Pharmacology Unit, different.
With so many regulations and so much confusion around biosimilars, it can often feel like patients have to choose between death or financial burden. Work with a CRO that can help you achieve the best biosimilar development program. Watch our latest webinar now to learn more.
Clinical Research, Oncology
In the following article by North Carolina Biotechnology Center, Dr. Elizabeth Witherspoon, NCBiotech Writer, discusses the strategic partnership between Worldwide and Deep Lens to utilize AI technology and develop a greater oncology focus in order to address rapidly changing trial needs.